However, when we examined a more sensitive marker such as urine exosomes that specifically look at podocyte derived protein such as podocalcyxin, nephrin and Wilm’s tumor we noted that canagliflozin appears to reduce these podocyte proteins particularly between visit 2 to 3. The gene discussed is NPHS1; the disease is Wilms tumor.